SCHEMBL5041342

SCHEMBL5041342

CCN(CCO)c1cc2sc(N)nc2[nH]1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 1/20 0.34
HTT P42858 1/20 0.34
PIK3CA P42336 5/20 0.33
PI4KA P42356 5/20 0.33
PI4KB Q9UBF8 5/20 0.33
PIK3CD O00329 4/20 0.33
PIK3CB P42338 4/20 0.33
PIK3CG P48736 4/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP3A4 P08684 3/20 0.32
DRD2 P14416 3/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
EPHX2 P34913 1/20 0.31
PIP5K1C O60331 1/20 0.31
ALDH1A1 P00352 2/20 0.31
TP53 P04637 2/20 0.31
TSHR P16473 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039616 0.92 CYP3A4 (0.34) HTTPIK3CAPI4KAPI4KBPIK3CD
SCHEMBL5039495 0.75 PDE3B (0.36) SLC29A1HTTNPC1RAB9ASTK4
SCHEMBL5036258 0.73 SLC29A1 (0.34) SLC29A1HTTNPC1RAB9ASTK4
SCHEMBL5040120 0.72 SLC29A1 (0.36) SLC29A1HTTPIK3CAPI4KAPI4KB
SCHEMBL12192588 0.70 PNP (0.38) SLC29A1HTTNPC1RAB9ACYP3A4
SCHEMBL5039736 0.70 SLC29A1 (0.34) SLC29A1HTTPIK3CAPI4KAPI4KB
SCHEMBL5039816 0.70
SCHEMBL5044525 0.69
SCHEMBL5041110 0.67 CYP2D6 (0.40) HTTPIK3CAPI4KAPI4KBPIK3CD
SCHEMBL5036562 0.66 PIK3CD (0.44) HTTPIK3CAPI4KAPI4KBPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1715840-B1 KERATIN DYEING COMPOSITIONS CONTAINING BICYCLIC FUSED 5-5 HETEROAROMATIC DYES PROCTER & GAMBLE (US) 2008-12-03 EP claimed
EP-1715840-B1 KERATIN DYEING COMPOSITIONS CONTAINING BICYCLIC FUSED 5-5 HETEROAROMATIC DYES PROCTER & GAMBLE (US) 2008-12-03 EP disclosed
US-7303590-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-04 US disclosed
CN-1917849-A Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE (US) 2007-02-21 CN disclosed
EP-1715840-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-11-02 EP disclosed
US-20050193502-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER, GAMBLE COMPANY, THE 2005-09-08 US disclosed
WO-2005077324-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050193502-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, KLK5, CKMT1A; CKMT1B SLC29A1 4838/4885HTT 2883/4885PIK3CA 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.